New FDA Chief Sheds Agency Hesitance On Drug Prices
The U.S. Food and Drug Administration's recently confirmed leader on Tuesday took fresh actions to jump-start approvals of lower-cost generics, making good on promises to focus the agency's mission more aggressively...To view the full article, register now.
Already a subscriber? Click here to view full article